BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 25998138)

  • 1. Outcomes of Sprint Fidelis and Riata lead extraction: Data from 2 high-volume centers.
    El-Chami MF; Merchant FM; Levy M; Alam MB; Rattan R; Hoskins MH; Langberg JJ; Delurgio D; Lloyd MS; Leon AR; Saba S
    Heart Rhythm; 2015 Jun; 12(6):1216-20. PubMed ID: 25998138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transvenous extraction of implantable cardioverter-defibrillator leads under advisory--a comparison of Riata, Sprint Fidelis, and non-recalled implantable cardioverter-defibrillator leads.
    Brunner MP; Cronin EM; Jacob J; Duarte VE; Tarakji KG; Martin DO; Callahan T; Borek PP; Cantillon DJ; Niebauer MJ; Saliba WI; Kanj M; Wazni O; Baranowski B; Wilkoff BL
    Heart Rhythm; 2013 Oct; 10(10):1444-50. PubMed ID: 23816440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transvenous extraction profile of Riata leads: procedural outcomes and technical complexity of mechanical removal.
    Bongiorni MG; Di Cori A; Segreti L; Zucchelli G; Viani S; Paperini L; De Lucia R; Levorato D; Boem A; Soldati E
    Heart Rhythm; 2015 Mar; 12(3):580-587. PubMed ID: 25499627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative outcomes of transvenous extraction of sprint fidelis and riata defibrillator leads: a single center experience.
    Richardson TD; Kolek MJ; Goyal SK; Shoemaker MB; Lewis AA; Rottman JN; Whalen SP; Ellis CR
    J Cardiovasc Electrophysiol; 2014 Jan; 25(1):36-42. PubMed ID: 24028661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of implantable cardioverter-defibrillator leads: a matter of lead size?
    Rordorf R; Poggio L; Savastano S; Vicentini A; Petracci B; Chieffo E; Klersy C; Landolina M
    Heart Rhythm; 2013 Feb; 10(2):184-90. PubMed ID: 23063430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter experience with extraction of the Riata/Riata ST ICD lead.
    Maytin M; Wilkoff BL; Brunner M; Cronin E; Love CJ; Grazia Bongiorni M; Segreti L; Carrillo RG; Garisto JD; Kutalek S; Subzposh F; Fischer A; Coffey JO; Gangireddy SR; Saba S; Mittal S; Arshad A; O'Keefe RM; Henrikson CA; Belott P; John RM; Epstein LM
    Heart Rhythm; 2014 Sep; 11(9):1613-8. PubMed ID: 24854215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biventricular defibrillator patients have higher complication rates after revision of recalled leads.
    Brumberg GE; Kaseer B; Shah H; Saba S; Jain S
    Pacing Clin Electrophysiol; 2012 Jun; 35(6):665-71. PubMed ID: 22519559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Class I recall of defibrillator leads: a comparison of the Sprint Fidelis and Riata families.
    Liu J; Brumberg G; Rattan R; Jain S; Saba S
    Heart Rhythm; 2012 Aug; 9(8):1251-5. PubMed ID: 22484652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Sprint Fidelis and Riata defibrillator lead failure rates.
    Fazal IA; Shepherd EJ; Tynan M; Plummer CJ; McComb JM
    Int J Cardiol; 2013 Sep; 168(2):848-52. PubMed ID: 23138013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on small-diameter implantable cardioverter-defibrillator leads performance.
    van Rees JB; van Welsenes GH; Borleffs CJ; Thijssen J; van der Velde ET; van der Wall EE; van Erven L; Schalij MJ
    Pacing Clin Electrophysiol; 2012 Jun; 35(6):652-8. PubMed ID: 22352338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sprint Fidelis implantable cardioverter-defibrillators lead patient management and survival: Single center study.
    Grabowski M; Rokicki JK; Gajda S; Januszkiewicz Ł; Cacko A; Stolarz P; Opolski G
    Cardiol J; 2017; 24(3):259-265. PubMed ID: 27910085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased incidence of subacute lead perforation noted with one implantable cardioverter-defibrillator.
    Danik SB; Mansour M; Singh J; Reddy VY; Ellinor PT; Milan D; Heist EK; d'Avila A; Ruskin JN; Mela T
    Heart Rhythm; 2007 Apr; 4(4):439-42. PubMed ID: 17399630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management and long-term outcomes associated with recalled implantable cardioverter-defibrillator leads: A multicenter experience.
    Mar PL; John A; Kumar S; Barry N; Chen G; Longserre S; Kabra R; Atkins D; Koerber S; Hussein A; Bhakta D; Lakkireddy D; Gopinathannair R
    Heart Rhythm; 2020 Nov; 17(11):1909-1916. PubMed ID: 32512178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Comparative Study of Defibrillator Leads at a Large-Volume Implanting Hospital: Results From the Pacemaker and Implantable Defibrillator Leads Survival Study ("PAIDLESS").
    Cohen TJ; Asheld WJ; Germano J; Islam S; Patel D
    J Invasive Cardiol; 2015 Jun; 27(6):292-300. PubMed ID: 26028656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased rate of subacute lead complications with small-caliber implantable cardioverter-defibrillator leads.
    Ellis CR; Rottman JN
    Heart Rhythm; 2009 May; 6(5):619-24. PubMed ID: 19389648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing hazard of Sprint Fidelis implantable cardioverter-defibrillator lead failure.
    Hauser RG; Hayes DL
    Heart Rhythm; 2009 May; 6(5):605-10. PubMed ID: 19285920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procedural outcomes associated with transvenous lead extraction in patients with abandoned leads: an ESC-EHRA ELECTRa (European Lead Extraction ConTRolled) Registry Sub-Analysis.
    Segreti L; Rinaldi CA; Claridge S; Svendsen JH; Blomstrom-Lundqvist C; Auricchio A; Butter C; Dagres N; Deharo JC; Maggioni AP; Kutarski A; Kennergren C; Laroche C; Kempa M; Magnani A; Casteigt B; Bongiorni MG;
    Europace; 2019 Apr; 21(4):645-654. PubMed ID: 30624715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transvenous extraction of advisory implantable cardioverter defibrillator leads with a relatively long implant duration.
    Goya M; Nagashima M; Hiroshima KI; Hayashi K; Makihara Y; Fukunaga M; An Y; Ohe M; Sasaki T; Shiohira S; Shirai Y; Kawabata M; Ando K; Isobe M; Hirao K
    J Cardiol; 2018 Oct; 72(4):316-320. PubMed ID: 29705082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome of implantable cardioverter defibrillators with recalled and non-recalled leads in Japanese patients. Increased failure rate of the Sprint Fidelis lead.
    Yanagisawa S; Inden Y; Shimano M; Yoshida N; Ichiyanagi H; Fujita M; Ohguchi S; Ishikawa S; Kato H; Okumura S; Miyoshi A; Nagao T; Yamamoto T; Hirai M; Murohara T
    Circ J; 2014; 78(2):353-9. PubMed ID: 24270680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes and Complications of Lead Removal: Can We Establish a Risk Stratification Schema for a Collaborative and Effective Approach?
    Fu HX; Huang XM; Zhong LI; Osborn MJ; Asirvatham SJ; Espinosa RE; Brady PA; Lee HC; Greason KL; Baddour LM; Sohail RM; Acker NG; Hodge DO; Friedman PA; Cha YM
    Pacing Clin Electrophysiol; 2015 Dec; 38(12):1439-47. PubMed ID: 26293652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.